Nuvation Bio Inc.
corporate_fare Company Profile
Nuvation Bio Inc. (NYSE:NUVB) is a publicly traded company in the Life Sciences sector. Wiseek monitors NUVB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Nuvation Bio Completes $287.5M Convertible Note Offering with Full Greenshoe Exercise
- Nuvation Bio Secures $287.5M in Convertible Notes as Underwriters Fully Exercise Greenshoe Option
- Nuvation Bio Completes $250M Convertible Note Offering at 35% Premium, Repays $58.5M Debt
- Nuvation Bio Finalizes $250M Convertible Note Offering at 35% Premium
- Nuvation Bio Prices Upsized $250M Convertible Note Offering at 35% Premium
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for NUVB, detected from its recent SEC filings · based on capital-structure filings through 2026-07-06.
Finalized Convertible Note Offering · Premium Conversion Price
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →